🇺🇸 FDA
Patent

US 10898478

Glucocorticoid receptor modulators to treat cervical cancer

granted A61KA61K31/337A61K31/4745

Quick answer

US patent 10898478 (Glucocorticoid receptor modulators to treat cervical cancer) held by Corcept Therapeutics Incorporated expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/337, A61K31/4745, A61P, A61P35/00